Thomas Samuel practices Oncology. He went to medical school at Stony Brook University School of Medicine. Thomas Samuel is a published physician as well. He has 1 publication published. The latest was: Is the era of HER2 over? Pertuzumab in the neoadjuvant treatment of early HER2-positive breast cancer.
NPI NUMBER | 1831187947 | |
NPPES Provider LastName | SAMUEL | |
NPPES Provider FirstName | THOMAS | |
NPPES Provider ZIPCode | 333313609 | |
NPPES Provider State | FL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 387.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 41.0 | |
Percent Opioid Claims | 10.59 |
National Provider Identifier [NPI] | 1831187947 |
Last Name Of The Provider | SAMUEL |
First Name Of The Provider | THOMAS |
View All |
Dr. Josh D. Simmons, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Anand P. Jillella, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Carlos H. Barcenas, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Alice K. David, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Richard H. Bromer, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Stephen M. Shlaer, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Olivier Rixe, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Jeremy C. Wells, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Savita Bidyasar, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |